As we continue to move through 2026, the life sciences landscape is shaped by a convergence of regulatory, enforcement, and market access developments that demand heightened attention from industry stakeholders.
ArentFox Schiff is proud to announce that the firm has been recognized as “Firm of the Year – Hatch-Waxman Litigation” at the LMG Life Sciences Americas Awards 2023.
ArentFox Schiff is pleased to announce that 130 attorneys have been recognized by The Best Lawyers in America 2024, with an additional four attorneys highlighted as “Lawyers of the Year” and 69 attorneys listed as “Ones to Watch.”
Partner Kevin Nelson shared his insight on the current state of biosimilar patent litigation and regulatory proceedings, and new challenges facing drug manufacturers in bringing biosimilar products to market.
ArentFox Schiff is pleased to announce that five attorneys have been ranked by LMG Life Sciences, which recognizes the work of outstanding individuals in the life sciences sector.
ArentFox Schiff is proud to announce that the firm and three of its attorneys have been ranked in the 2022 edition of IAM Patent 1000: The World’s Leading Patent Professionals, a guide that identifies top patent professionals based on interviews with private practice and in-house professionals.
Partner Kevin Nelson was quoted on a Federal Circuit Court ruling in GlaxoSmithKline v. Teva, which has caused concern among some generic drug manufacturers regarding their ability to sell generic drugs that leave patent-protected uses off the label.
Partner Imron Aly was quoted regarding a letter from the U.S. Food and Drug Administration (FDA) sent to the U.S. Patent and Trademark Office (USPTO) with suggestions on how to prevent some patent-owning pharmaceutical companies from blocking generics from entering the market.
Intellectual Property Practice Group Co-Leader Imron Aly was quoted on the recent U.S. Supreme Court ruling in Minerva v. Hologic. The decision modified and limited the previous bar on inventors from challenging the validity of their patents after they have been assigned to others.
Schiff Hardin LLP is proud to announce that the firm and four of its attorneys have been ranked in the 2021 edition of IAM Patent 1000: The World’s Leading Patent Professionals, a guide that identifies top patent professionals based on 1,800 interviews with private practice and in-house professionals.